Albuminuria in ischemic heart disease

References

• Yudkin J S, Forrest R D, Jackson C A. Microalbuminuria as predictor of vascular disease in non diabetic subjects. Lancet 1988; II: 530–3
   Google Scholar
• Damsgaard E M, Frøland A, Jørgensen O D, Mogensen C E. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297–300
   PubMed Web of Science ®Google Scholar
• Mathiesen E R. Prevention of diabetic nephropathy. Danish Medical Bulletin 1993; 40: 273–85
   PubMedGoogle Scholar
• Bennet P H, Haffner S, Kasiske B L, Keane W F, Mogensen C E, Parving H H, Steffes M W, et al. Screening and management of microalbuminuria in patients with diabetes mellitus. Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the Counsil on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995; 25(1)107–112
   PubMedGoogle Scholar
• Gosling P, Hughes E A, Reynolds T M, Fox J P. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J. 1991; 12: 508–13
   PubMed Web of Science ®Google Scholar
• Berton G, Citro T, Palmieri R, Petucco S, De Toni R, Palatini P. Albumin Excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation 1997; 96: 3338–3345
   PubMed Web of Science ®Google Scholar
• Ellekilde G, von Eyben F E, Holm J, Hemmingsen L. Above-normal urinary excretion of albumin and retinol-binding protein in patients with acute myocardial infarction. Clinical Chemistry 1993; Vol. 39(11)
   PubMedGoogle Scholar
• Nielsen S H, Jensen J EB, Magid E. Episodic albuminuria in acute ischaemic heart disease. Lancet (Letter) 1994; 343: 732
   PubMedGoogle Scholar
• Kordonouri O, Jörres A, Müller C, Enders I, Gahl G M, Weber B. Quantitative assessment of urinary protein and enzyme excretion - a diagnostic programme for the detection of renal invovement in type I diabetes mellitus. Scand J Clin Lab Invest 1992; 52: 781–90
   PubMed Web of Science ®Google Scholar
• Guder W G, Hofmann W. Markers for the diagnosis and monitoring of renal tubular lesions. Clin Nephrol 1992; 38: 3–7, (suppl 1)
   PubMed Web of Science ®Google Scholar
• Axelsen N H. Intermediate gel in crossed and in fused rocket immunoelectrophoresis. Scand J Immun 1973; 2: 71–7, (suppl 1)
   Web of Science ®Google Scholar
• Whicher J T, Ritchie R F, Johnson A M, Baudner S, Bienvenu J, Blirup-Jensen S, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994; 40: 934–8
   PubMed Web of Science ®Google Scholar
• Hofman W, Guder W G. A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 1989; 27: 589–600
   PubMedGoogle Scholar
• Lynch M, Pentecost B L, Littler W A, Stockley R A. Proteinuria with streptokinase. Lancet (Letter) 1993; 341: 1024
   PubMedGoogle Scholar
• Shearman C P, Gosling P, Walker K J. Is low proteinuria an early predictor of severity of acute pancreatitis?. J Clin Pathol 1989; 42: 1132–5
   PubMed Web of Science ®Google Scholar
• Gosling P, Sanghera K, Dickson G. Generalized vascular permeability and pulmonary function in patients following serious trauma. J Trauma 1994; 36: 477–81
   PubMed Web of Science ®Google Scholar
• Gosling P, Suttcliffe M AC, Cooper S, Jones A F. Burn and trauma associated proteinuria: the role of lipid peroxidation, renin and myoglobin. Ann Clin Biochem 1988; 25: 53–9
   PubMedGoogle Scholar
• Smith F CT, Gosling P, Sanghera K, Green M A, Paterson I S, Shearman C P. Microproteinuria predicts severity of systemic effects of reperfusion injury following infrarenal aortic aneurysm surgery. Ann Vasc Surg 1994; 8: 1–5
   PubMedGoogle Scholar
• Tencer J, Thysell H, Andersson K, Grubb A. Stability of albumin, protein HC, immunoglobulin G, kappa-and lambda-chain immunoreactivity, orosomucoid and alpha-1-antitrypsin in urine stored at various conditions. Scand J Clin Lab Invest 1994; 54: 199–206
   PubMed Web of Science ®Google Scholar
• Ito S, Tsuda A, Momotsu T, Igarashi K, Kasahara S, Satoh K, Shibata A. Urinary orosomucoid excretion rate in patients with non-insulin-dependent diabetes mellitus. Acta Endocrinologica (Copenh) 1989; 120: 584–90
   PubMedGoogle Scholar
• Johnsson E, Haraldsson B. Addition of purified orosomucoid preserves the glomerular permeability for albumin in isolated perfused rat kidneys. Acta Physiol Scand 1993; 147: 1–8
   PubMedGoogle Scholar
• Suval W D, Duran W N, Boric M P, Hobson R W, Berendsen P B, Ritter A B. Microvascular transport and endothelial cell alterations preceding skeletal muscle damage in ischemia and reperfusion injury. Am J Surg 1987; 154: 211–8
   PubMed Web of Science ®Google Scholar
• Abe Y., Kawakami M, Kuroki M, Yamamoto T, Fujii M, Kobayashi H, et al. Transient rise in serum interleukin-8 concentration during acute myocardial infarction. Br Heart J 1993; 70: 132–4
   PubMedGoogle Scholar
• Änggård E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199–1206
   PubMed Web of Science ®Google Scholar
• Shearman C P, Gosling P, Gwynn B R, Simms M H. Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease?. Eur J Vasc Surg. 1988; 2: 401–4
   PubMedGoogle Scholar
• Hickey N C, Gosling P, Baar S, Shearman C P, Simms M H. Effects of surgery on the systemic inflammatory response to intermittent claudication. Br J Surg 1990; 77: 1121–24
   PubMedGoogle Scholar
• Rouleau J L, Moyé L A, de Champlain J, Klein M, Bichet D, Packer M. Activation of neurohumoral systems following acute myocardial infarction. Am J Cardiol 1991; 68: 80D–86D
   PubMedGoogle Scholar
• Ray S G, Morton J J, Dargie H J. Relationship of renin, angiotensin II and atrial natriuretic factor to clinical status in the early post-infarct period in patients with left ventricular dysfunction. Eur Heart J 1994; 15: 793–800
   PubMedGoogle Scholar
• Bohrer M P, Deen W M, Robertson C R, Brenner B M. Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol 1977; 233: F13–21
   Google Scholar
• Sala C, Cuspidi C, Sampieri L, Zanchetti A. Increase of plasma atrial natriuretic peptide during cardiac ischemia induced by dipyridamole echo-stress. XIII th World Congress of Cardiology, Rio de JaneiroBrazil, April, 26–301998, Abstract 2395
   Google Scholar
• Grisold M, Klein W, Gasser R. The cardioprotective role of ANP during myocardial ischemia: experimental and clinical data. XXth Congress of the European Society of Cardiology, ViennaAustria, August, 22–261998, Abstract: P2943
   Google Scholar
• Cha-Po Lai, Egashira K, Tashiro H, Narabayashi H, Koyanagi S, Imaizumi T, Takeshita A. Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris. Circulation 1993; 87: 144–151
   PubMedGoogle Scholar
• Eiskjær H, Mogensen C E, Schmitz A, Pedersen E B. Enhanced urinary excretion of albumin and beta-2-microglobulin in essential hypertension induced by atrial natriuretic peptide. Scand J Clin Lab Invest 1991; 51: 359–366
   PubMedGoogle Scholar
• Plum J, Mirzaian Y, Grabensee B. Atrial natriuretic peptide, sodium retension, and proteinuria in nephrotic syndrome. Nephrol dial Transplant 1996; 11: 1034–42
   PubMed Web of Science ®Google Scholar
• Vervoort G, Hertenberg F, Wetzels J F, Smits P. Influence of angiotensin converting enzyme inhibition and angiotensin II type I receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers. J Hypertens 1998; 16(2)245–50
   PubMedGoogle Scholar
• McMurray J, Seidelin P H, Howey J E, Balfour D J, Struthers A D. The effect of atrial natriuretic factor on urinary albumin and beta-2-microglobulin excretion in man. J Hypertens 1998; 6(10)783–6
   Google Scholar
• Erley C M, Grau C, Furian T C, Wolf S, Braun N, Risler T. Subpressor doses of angiotensin II do not increase albumin excretion in humans. Clin Nephrol 1996; 46: 312–8
   PubMedGoogle Scholar
• Cohen N, Phillips P, Gilbert R, Jerrums G. Dissociation of blood pressure and albuminuria in normal subjects infused with angiotensin II and noradrenalin. Clin Exp Pharmacol Physiol 1993; 20: 317–9
   PubMedGoogle Scholar